Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Histone Deacetylase Inhibitors (HDACi) Promote KLF5 Ubiquitination and Degradation in Basal-like Breast Cancer
Yanjie Kong, Wenlong Ren, Huan Fang, et al.
International Journal of Biological Sciences (2022) Vol. 18, Iss. 5, pp. 2104-2115
Open Access | Times Cited: 18

Showing 18 citing articles:

Protein acylation: mechanisms, biological functions and therapeutic targets
Shuang Shang, Jing Liu, Fang Hua
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 94
Advances in targeting histone deacetylase for treatment of solid tumors
Mu-Qi Shi, Ying Xu, Xin Fu, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 23
Epigenetic regulation in cancer therapy: From mechanisms to clinical advances
Lei Tao, Yue Zhou, Yuan Luo, et al.
MedComm – Oncology (2024) Vol. 3, Iss. 1
Open Access | Times Cited: 19
KLF5 Promotes Tumor Progression and Parp Inhibitor Resistance in Ovarian Cancer
Yong Wu, Siyu Chen, Yang Shao, et al.
Advanced Science (2023) Vol. 10, Iss. 31
Open Access | Times Cited: 19
KLF5 inhibition potentiates anti-PD1 efficacy by enhancing CD8+ T-cell-dependent antitumor immunity
Qi Wu, Zhou Liu, Zhijie Gao, et al.
Theranostics (2023) Vol. 13, Iss. 4, pp. 1381-1400
Open Access | Times Cited: 18
Acetylation: a new target for protein degradation in cancer
Callie E. W. Crawford, George M. Burslem
Trends in cancer (2025)
Closed Access
TGF-β-Induced Acetylation of KLF5 Drives TNFAIP2 Transcription and EMT in Nasopharyngeal Carcinoma: Unveiling a Novel Regulatory Mechanism
Yi Qian, Xuxu Zhao, Feifei Wu, et al.
Experimental Cell Research (2025) Vol. 447, Iss. 1, pp. 114498-114498
Closed Access
Histone Deacetylase Inhibitors in the Management of Advanced Cancers
Nicolas Sayegh, Valerie Etzrodt
JCO Precision Oncology (2025), Iss. 9
Closed Access
Current treatment strategies targeting histone deacetylase inhibitors in acute lymphocytic leukemia: a systematic review
Yingjun Zhang, Ge Zhang, Yuefang Wang, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 4
KLF5 inhibition initiates epithelial-mesenchymal transition in non-transformed human squamous epithelial cells
Dharmendra Bhargava, David Rusakow, Wilson Zheng, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (2024) Vol. 1871, Iss. 7, pp. 119789-119789
Closed Access | Times Cited: 2
Elevated choline drives KLF5-dominated transcriptional reprogramming to facilitate liver cancer progression
Xinrong Li, Zhixiang Hu, Qili Shi, et al.
Oncogene (2024)
Closed Access | Times Cited: 2
Pre-pubertal oocytes harbor altered histone modifications and chromatin configuration
Pe’era Wasserzug Pash, Gilad Karavani, Eli Reich, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 10
Open Access | Times Cited: 6
The HDAC inhibitor HFY-4A improves TUSC2 transcription to induce immunogenic cell death in breast cancer
Yongshuo Yin, Xiao Guan, Genju Li, et al.
Toxicology and Applied Pharmacology (2023) Vol. 478, pp. 116698-116698
Closed Access | Times Cited: 5
Prospects for breast cancer immunotherapy using microRNAs and transposable elements as objects
Р. Н. Мустафин
Exploration of Targeted Anti-tumor Therapy (2024) Vol. 5, Iss. 5, pp. 1011-1026
Open Access | Times Cited: 1
Upregulated PARP1 confers breast cancer resistance to CDK4/6 inhibitors via YB-1 phosphorylation
Chuntao Quan, Zhijie Wu, Juan Xiong, et al.
Experimental Hematology and Oncology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 3
Advances in Biomarkers and Endogenous Regulation of Breast Cancer Stem Cells
Wen‐Ming Chen, Lu Zhang, Suling Liu, et al.
Cells (2022) Vol. 11, Iss. 19, pp. 2941-2941
Open Access | Times Cited: 4
LN-439A, a novel BAP1 inhibitor, suppresses the growth of basal-like breast cancer by degrading KLF5
Tiantian Wang, Long-long Zhang, Fubing Li, et al.
Acta Pharmacologica Sinica (2024)
Closed Access
Sublytic C5b-9 induces TIMP3 expression by glomerular mesangial cells via TRAF6-dependent KLF5 K63-linked ubiquitination in rat Thy-1 nephritis
Shuai Ying, Longfei Liu, Can Luo, et al.
International Immunopharmacology (2023) Vol. 124, pp. 110970-110970
Closed Access | Times Cited: 1
Page 1

Scroll to top